Posted on 09/17/2016 6:43:07 AM PDT by TigerLikesRooster
Edited on 09/17/2016 8:30:38 AM PDT by Admin Moderator. [history]
Now it's official: Monsanto is going to be swallowed up by a rival in the biggest takeover announced so far this year.
To clinch a deal, Germany's Bayer pumped even more money into its bid for the U.S. seed giant, valuing it at $66 billion, including debt.
(Excerpt) Read more at money.cnn.com ...
I would suspect some politician got rich over the deal.
P!
Bayer and BASF are the ones that built Auschwitz. They wanted free labor to make drugs. This nation is under the thumb of the globalist crime families.
So it may turn out to be a headache.
I heard it may not go through. It has to be approved by the EU, which has banned GM food. They don’t believe Bayer will control it.
It’s like a wedding between Evita Peron and Benito Mussolini.
All of the money right down to the consultant and trust funds
German globalists controlling food and seed technology. What could go wrong?
This has yet to pass regulatory scrutiny, thus not a done deal! Watching Fox Business' Wall Street program last night and saw them give this only about a 40% chance of passage as a complete deal. In terms of regulators, due to the scope of both companies, they listed 5 hurdles; US, EU, Canada and Brazil? Don't know what the 5th was but 5 regulators is a high reach.
Monsanto apparently has a guarantee from Bayer of $2billion if the deal is stopped. Stock price of Monsanto is $20/share UNDER the Bayer offer so there is not a great amount of confidence in the market traders for this deals completion.
When one multi-national, quasi-governmental entity absorbs another it is inaccurate to use the term “capitalism” to describe the event.
Trump.
As long as such assets remained in the hands of compliant fellow globalists in DC, everything was cool.
The libs will have to redo all their facebook graphics about Monsanto killing everyone. “Bayer” just won’t sound as evil. They’ve got their work cut out for them if the deal goes through.
Not a good combination.
Bayer just got put on my ban list for owning evil Monsanto.
Except without the warmth those two exuded.
Bayer opens large China plant for traditional Chinese and Western OTC meds
Expansion of production in China
Bayer HealthCare will invest around €100 million to considerably expand its production capacities in Beijing, China, in preparation for an increase in the demand for its products there. Bayer CEO Dr. Marijn Dekkers signed an agreement to this effect during the visit to Germany by Chinese President Xi Jinping. The planned capacity expansion is designed to ensure a reliable supply of high-quality products from Bayer HealthCare, particularly in the areas of cardiovascular diseases and diabetes, to meet Chinese domestic demand.
http://www.stockholders-newsletter-q1-2014.bayer.com/en/expansion-of-production-in-china.aspx
Bayer Biological seed treatment
In a move aimed at further expanding its global seed business, Bayer CropScience has signed an agreement to acquire Biagro Group, a producer and distributor of biological seed treatment solutions headquartered in Gral. Las Heras in the province of Buenos Aires, Argentina.
Established in 1984, Biagro has approximately 140 employees and production facilities in Argentina and Brazil. Its portfolio of established brands includes seed-applied inoculants, plant-growth-promoting microorganisms and other products for integrated pest management based on bacterial and fungal strains.
Bayer plans to acquire Chinese Dihon Pharmaceutical
Bayer has signed an agreement to acquire Dihon Pharmaceutical Group Co., Ltd., Kunming Yunnan, China, a privately held pharmaceutical company specializing in the manufacture and marketing of over-the-counter (OTC) and herbal traditional Chinese medicine (TCM) products.
The acquisition will strengthen Bayer’s presence in China. Dihon is a leading player in China’s OTC industry with products such as Kang Wang™ for the treatment of dandruff and other scalp disorders and Pi Kang Wang™, an antifungal cream, as well as TCM product Dan E Fu Kang™ for use in various women’s health indications.
The transaction is subject to fulfillment of certain conditions, including merger control clearance, and is expected to close in the second half of 2014. “We aim to strengthen our Life Sciences portfolio with strategic bolt-on acquisitions globally. We are very pleased to have identified a consumer health care company in China with such a strong track record of success built by its dedicated employee base,” said Bayer CEO Dr. Marijn Dekkers.
Good one :)
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.